Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Achieve Life Sciences Inc ACHV

Healthcare Biotechnology
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of... see more

Recent & Breaking News (NDAQ:ACHV)

32 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  March 15, 2019

Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update

PR Newswire March 14, 2019

The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering

Benzinga.com  March 14, 2019

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019

PR Newswire March 5, 2019

Predictive Technology Group Names Jay M. Moyes to Its Board of Directors

GlobeNewswire February 28, 2019

72 Biggest Movers From Yesterday

Benzinga.com  February 26, 2019

41 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  February 25, 2019

Mid-Day Market Update: Crude Oil Down 2.5%; Titan Pharmaceuticals Shares Spike Higher

Benzinga.com  February 25, 2019

Thinking about buying stock in Achieve Life Sciences, Kraft Heinz Co., Liquidia, Roku or Zillow?

PR Newswire February 25, 2019

28 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  February 25, 2019

71 Biggest Movers From Friday

Benzinga.com  February 25, 2019

Mid-Afternoon Market Update: Wayfair Jumps After Strong Q4 Results; Stamps.com Shares Slide

Benzinga.com  February 22, 2019

26 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  February 22, 2019

Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting

PR Newswire February 22, 2019

Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation

PR Newswire February 20, 2019

The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas

Benzinga.com  December 19, 2018

Achieve Announces Update on Cytisinicline Clinical Development Program

PR Newswire December 18, 2018

The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering

Benzinga.com  December 6, 2018

The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results

Benzinga.com  November 15, 2018

The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut

Benzinga.com  November 14, 2018